Design and Synthesis of biologically active compounds containing S and N heterocycles
1 Designed and synthesized biologically active heterocyclic compounds such as thiazolidin-4-one, Pyrazoline, Pyrimidine, imidazole and chromene derivatives
1 Synthesis of biologically active heterocyclic compounds such as novel sulphur and nitrogen containing ferrocenyl linked heterocyclic compounds, novel 6-ferrocenyl-4-aryl-2-substituted pyrimidines, novel pyrimidine‐based ferrocenyl substituted organometallic compounds, novel pyrazoline‐based organometallic compounds, Organometallic macromolecules such as ferrocenyl bis-pyrazoline and bis-pyrimidine derivatives, 2,4,6 trisubstituted bis-pyrimidines, bis-dioxazoles, carbamates, thiosemicarbazones and hydroxy pyrazolines, tetrazoles, and fatty acid derivatives
2 Developed three non infringing Processes (Routes) to prepare Cinacalcet HCl (API) chemically designated as N-[l-(R)-(-)-(l-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-l-aminopropane hydrochloride The Drug Cinacalcet HCl is used for the treatment of secondary hyper parathyroidism in patients with chronic kidney disease on dialysis and for the treatment of hypercalcemia in patients with parathyroid carcinoma